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Abstract
HIV infection has a profound effect on “bystander” cells causing metabolic co-morbidities.
This may be mediated by exosomes secreted by HIV-infected cells and containing viral fac-
tors. Here we show that exosomes containing HIV-1 protein Nef (exNef) are rapidly taken
up by macrophages releasing Nef into the cell interior. This caused down-regulation of
ABCA1, reduction of cholesterol efflux and sharp elevation of the abundance of lipid rafts
through reduced activation of small GTPase Cdc42 and decreased actin polymerization.
Changes in rafts led to re-localization of TLR4 and TREM-1 to rafts, phosphorylation of
ERK1/2, activation of NLRP3 inflammasome, and increased secretion of pro-inflammatory
cytokines. The effects of exNef on lipid rafts and on inflammation were reversed by overex-
pression of a constitutively active mutant of Cdc42. Similar effects were observed in macro-
phages treated with exosomes produced by HIV-infected cells or isolated from plasma of
HIV-infected subjects, but not with exosomes from cells and subjects infected with ΔNef-
HIV or uninfected subjects. Mice injected with exNef exhibited monocytosis, reduced
ABCA1 in macrophages, increased raft abundance in monocytes and augmented inflamma-
tion. Thus, Nef-containing exosomes potentiated pro-inflammatory response by inducing
changes in cholesterol metabolism and reorganizing lipid rafts. These mechanisms may
contribute to HIV-associated metabolic co-morbidities.
Author summary
HIV infects only a limited repertoire of cells expressing HIV receptors. Nevertheless, co-
morbidities of HIV infection, such as atherosclerosis, dementia, renal impairment, myo-
cardial pathology, abnormal haematopoiesis and others, involve dysfunction of cells that
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can not be infected by HIV. These co-morbidities persist even after successful application
of antiretroviral therapy, when no virus is found in the blood. Many co-morbidities of
HIV have a common element in their pathogenesis, impairment of cholesterol metabo-
lism. In this study we show that HIV protein Nef released from infected cells in extracellu-
lar vesicles is taken up by un-infected (‘bystander’) cells impairing cholesterol metabolism
in these cells. This impairment causes formation of excessive lipid rafts, re-localization of
the inflammatory receptors into rafts, and triggers inflammation. These mechanisms may
contribute to HIV-associated metabolic co-morbidities. Our work demonstrates how a
single viral factor released from infected cells into circulation may cause a pleiotropy of
pathogenic responses.
Introduction
HIV productively infects CD4+ T-cells, macrophages and related cells expressing CD4 receptor
and CCR5 or CXCR4 co-receptors, but not other cell types that lack these molecules, and can-
not replicate in tissues where susceptible cells are underrepresented. Nevertheless, clinical
manifestations of HIV infection often involve dysfunction of cells and tissues which are not,
and could not be, infected by HIV. HIV disease is associated with numerous co-morbidities,
such as atherosclerosis, metabolic syndrome, myocardial pathology, abnormal adipose tissue,
dementia, respiratory complications, abnormal haematopoiesis, and many others [1]. Para-
doxically, many co-morbidities persist, albeit with reduced severity, even after successful appli-
cation of antiretroviral therapy (ART), when no virus is detected in the blood and
immunodeficiency is mitigated. One example is atherosclerosis and dyslipidaemia associated
with HIV infection [2]. Pathogenesis of these co-morbidities involves vascular endothelial and
smooth muscle cells as well as hepatic cells, none of which susceptible to HIV infection. Mac-
rophages, which are also involved in pathogenesis of atherosclerosis, can be infected by HIV,
however, the proportion of infected monocytes in blood and macrophages in tissues of ART-
treated patients is too low to be a major driver of systemic atherosclerosis. One explanation of
the systemic pathology in treated HIV infection is “bystander” effects. The effect of HIV infec-
tion on bystander cells has been described (for review see [3]) and was attributed to individual
HIV proteins released from infected cells [4, 5] and taken up by uninfected cells. Nef (Negative
Regulatory Factor), for example, is known to affect tissues through cytotoxicity, and other HIV
proteins released from infected host cells may contribute to the systemic effects of the infection
in various ways [6]. These effects can take place even in the context of effective anti-retroviral
treatment due to ongoing expression of HIV proteins in long-living infected cells and HIV
replication in viral reservoirs [5, 7]. Nef was found in blood of HIV-infected patients receiving
ART [8, 9].
Many of the diverse co-morbidities of HIV disease have a common element that plays a
prominent role in their pathogenesis, impairment of cholesterol metabolism. Cholesterol also
plays a key role in the lifecycle of HIV, and HIV interacts with host cholesterol metabolism
machinery [10]. We have previously identified the molecular mechanism by which HIV infec-
tion affects cholesterol metabolism [11]. HIV targets a pathway responsible for removal of
excessive cholesterol from peripheral cells, reverse cholesterol transport pathway, and the key
element of this pathway, lipid transporter ATP binding cassette transporter type A1 (ABCA1).
We demonstrated the central role of the viral protein Nef in this activity: Nef inactivates host
cell’s ABCA1 leading to reduction of cholesterol efflux and accumulation of intracellular cho-
lesterol [11–13]. The concentration of free Nef in plasma of HIV-infected patients is, however,
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very low, and most Nef is secreted by HIV-infected cells in exosomes [9]. Exosomes were
implicated in pathogenesis of HIV disease [14] and are increasingly considered an important
way of cell-to-cell communication ensuring rapid and targeted delivery of the molecules from
one cell to another [15]. The contribution of Nef-containing exosomes to systemic effects of
HIV infection [16] and to pathogenesis of HIV-associated dementia [17] has been proposed.
In this study, we investigated the effect of Nef-containing exosomes on uninfected macro-
phages and identified the mechanism that may play a key role in pathogenesis of several meta-
bolic co-morbidities of HIV infection.
Results
Delivery of Nef by exosomes
We opted for the approach allowing investigation of the effects of Nef without interference of
other HIV proteins because our previous studies demonstrated that Nef alone is fully responsi-
ble for the effects of HIV on cholesterol metabolism [11]. Nef-containing and control exo-
somes were generated in HEK293 cells transfected with, respectively, NefSF2 or GFP. When
indicated, cells were transfected with Nef tagged with GFP.
Cell culture media was collected every 48 h for 8 days after transfection and extracellular
vesicles (EV) were isolated by polyethylene glycol precipitation—based method. Size of the iso-
lated EVs was analysed by electron microscopy; size distribution and a representative EM
micrograph are shown in Fig 1A. Majority of the EVs were 120±20 nm, characteristic for exo-
somes [15]. The exosomal marker, Alix, was considerably enriched in EV preparations com-
pared with its abundance in the cells (Fig 1B). We therefore termed the EVs used in this study
exosomes, although it is recognized that exosomes in our preparations are likely to contain
other types of EVs.
Exosomes isolated from Nef-expressing cells contained Nef (Fig 1B). To measure the con-
centration of Nef in Nef-containing exosomes (exNef), we generated a calibration curve using
purified non-myristoylated recombinant Nef (rNef) produced using bacterial expression sys-
tem, and quantitated the density of bands corresponding to recombinant and exosomal Nef
using Western blot (Fig 1C). The Nef content of the exosomes showed considerable variability
from one preparation to another, however, on average there was 0.5 ng Nef per 1 μg of total
exosomal protein. In the experiments reported here, Nef concentration was determined for
each individual preparation of exosomes. Total protein content of exosomes was measured,
and GFP-containing exosomes (exGFP, control) were added at the same total protein concen-
tration as Nef-containing exosomes.
To study the dynamics of exosome uptake, we labelled exosomes with fluorescent dye,
PKH67, and incubated them with RAW264.7 macrophages for the indicated periods of time.
Exosomes appeared in the cells after 10 min of incubation and were located in proximity to the
plasma membrane (Fig 1D). Continuous incubation led to an almost linear increase in the
abundance of labelled exosomes inside the cells for 6 h, followed by a slower uptake for at least
another 42 h, with exosomes found across the cytosol (Fig 1D and 1E); there was no non-spe-
cific uptake of the dye (Fig 1D). Quantitation of exNef uptake by measuring total fluorescence
intensity in the cells indicated that over 20% of added exosomes were taken up by cells after 6
h incubation (Fig 1F). When cells were loaded with exosomes for 48 h and unbound exosomes
washed out, the abundance of labelled exosomes in the cells gradually decreased during 24 h,
but up to 50% of exosomes originally taken up were retained by the cells for up to 120 h (Fig
1G). Staining of cells treated with exosomes containing GFP-tagged Nef (exNef-GFP) with
anti-GFP antibody demonstrated that Nef-GFP could be detected in cells’ interior after 24 h
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Fig 1. Nef-containing exosomes deliver Nef to macrophages. A—Size distribution of the extracellular vesicles secreted by HEK293
cells determined by EM; Inset–EM micrograph of the vesicles; bar– 200 nm. B—Western blot for the exosomal marker Alix and Nef
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incubation with the exosomes (Fig 1H). Thus, Nef-containing exosomes were rapidly and
quantitatively taken up by macrophages, delivering Nef to the intracellular compartments.
It was previously suggested that exosomes produced by Nef-expressing cells contain Nef
mRNA, which can be taken up and used to synthesize endogenous Nef in target cells [17].
Using RNAseq analysis we were unable to detect Nef mRNA in Nef-containing exosomes
(deposited to GEO, accession #GSE122657).
Nef-containing exosomes alter cholesterol metabolism
Our previous studies documented reduction of cholesterol efflux and ABCA1 abundance in
macrophages infected with Nef-expressing HIV [11]. A similar effect was observed when
recombinant myristoylated Nef was added to macrophages [13]. Here, we compared the effects
of two forms of exogenously added Nef, exosomal Nef and myristoylated recombinant Nef
produced in baculovirus expression system. Dose-dependence of the effect of exNef on choles-
terol efflux from RAW264.7 macrophages is shown in Fig 2A, demonstrating a reduction of
cholesterol efflux after a 48 h incubation with exNef at concentration as low as 0.1 ng/ml (3.3
nmol/L). ExGFP had no effect on cholesterol efflux at exosome concentrations equivalent to
the highest concentration of exNef (Fig 2B and 2G). When we compared side-by-side the
effects of rNef and exNef on cholesterol efflux from RAW264.7 cells after 48 h incubation,
exNef caused the same level of reduction of cholesterol efflux as rNef at concentration 250-fold
lower (exNef—0.4 ng/ml (13.2 nMol/L) versus rNef 100 ng/ml (3.3 μMol/L, minimal effective
concentration)) (Fig 2B). Correspondingly, exNef caused a similar reduction in the abundance
of total and cell-surface ABCA1 at a 250-fold lower concentration compared to rNef (Fig 2C).
To ensure that the findings with exNef were not specific to RAW264.7 cells, we repeated these
experiments using primary cells, murine bone marrow derived macrophages (BMDM). Simi-
lar to RAW264.7 cells, exNef was effective in reducing cholesterol efflux (Fig 2D) and abun-
dance of total and cell-surface ABCA1 (Fig 2E) in BMDM at concentrations 250-fold lower
than concentrations of rNef that caused similar effects. The higher functional efficiency of
exNef is most likely explained, at least partially, by a much higher efficiency of the uptake of
exosomes by target cells via endocytic pathways, in comparison to rNef that does not have a
specific receptor [18]. Indeed, inhibition of endocytosis by silencing Dynamin-2, a common
element of several endocytic pathways, partially inhibited the effects of exNef on the abun-
dance of ABCA1 (Fig 2F), indicating involvement of active endocytic pathways in the exNef
activity. To ensure that the exosomes themselves do not produce similar functional effects, we
compared the effects of exNef and exGFP with that of exosomes produced by un-transfected
cells and of the vehicle (Fig 2G and 2H). Only Nef-containing exosomes reduced cholesterol
efflux and abundance of total and cell-surface ABCA1, supporting the notion that the effects
on cholesterol efflux and ABCA1 were caused by Nef. Finally, we compared exosomes isolated
from plasma of uninfected volunteers and from HIV-infected subjects. Plasma was pooled
from 4 uninfected and from 4 HIV-infected subjects undergoing treatment with ART and
described in our recent study [19]. Exosomes from HIV-infected, ART treated donors (HIV+)
reduced cholesterol efflux as well as abundance of total and cell-surface ABCA1 compared to
exosomes from uninfected individuals (Fig 2I and 2J).
in cells and exosomes (exNef); C—Western blot for the indicated amounts of rNef and in a typical preparation of exNef (10 μg of
exosomal protein); D, E–Time-course of exosome uptake quantitated by confocal microscopy; F–Time-course of exosome uptake
quantitated by fluorimetry; percentage of added exosomes that was taken up is shown; G–Cells were incubated with exosomes for 48
h, excess exosomes was washed out and cells incubated for the indicated periods of time in exosome-free medum; retained
fluorscence of the exosome stain PKH67 was assessed using confocal microscopy; H–Visualisation of Nef-GFP inside the cells after
exposure to exNef-GFP (5 μg/ml of exosomal protein) after staining with anti-GFP antibody. Scale bars– 10 μm.
https://doi.org/10.1371/journal.ppat.1007907.g001
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Fig 2. Exosomal Nef is more active than recombinant Nef. A—Dose-dependence of the effect of exNef on cholesterol efflux after 48 h exposure. �p<0.05,
��p<0.01 versus control; B—Comparison of the effects of rNef (100 ng/ml) and exNef (0.4 ng/ml) on cholesterol efflux after 48 h exposure; ��p<0.01 versus
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Next, we investigated the dynamics of the effect of exNef on cellular cholesterol metabolism.
ExNef reduced the abundance of both total and cell-surface ABCA1 in RAW264.7 cells in a
time-dependent manner (Fig 3A). After a 48 h exposure to exNef, the abundance of total
ABCA1 was reduced by 42±1%, and that of cell-surface ABCA1—by 40±1% (mean ± SEM,
p<0.01; n = 3). Expression of Abca1 was increased after a 24 h exposure to exNef, but there
was no statistical difference in Abca1 expression after 48 h of exposure between exGFP and
exNef (Fig 3B). The discrepancy between ABCA1 abundance and gene expression indicates
that regulation of ABCA1 abundance by exNef mainly occurs at a post-transcriptional level, as
we suggested for endogenously expressed Nef [20]. On average, cholesterol efflux to apoA-I
was reduced by 40±3% (mean ± SEM, p<0.05; n = 6) after 48 h exposure to exNef (Fig 3C).
To investigate the duration of the Nef effects, we incubated cells with exNef for 48 h, then
removed exNef and incubated cells for further 48 h in the exosome-free media. Unexpectedly,
the effects of exNef on cholesterol efflux (Fig 3D) and ABCA1 abundance (Fig 3E) became
even stronger after removal of exNef from the media, indicating that Nef delivered by exo-
somes remains active within the cells for at least 48 h. The abundance of another cholesterol
transporter, ATP Binding Cassette Transporter G1 (ABCG1), was not affected by exNef (Fig
3E). We also tested an option of constant delivery of exosomes by co-culturing GFP- or Nef-
transfected HEK293 cells with RAW264.7 cells in chambers of a transwell for 48 h. Again, the
abundance of total ABCA1 was reduced in RAW264.7 cells exposed to the media produced by
Nef-expressing compared to GFP-expressing HEK293 cells (Fig 3F). Finally, we tested the
effects of exNef on human macrophages. Exposure of differentiated THP-1 cells to exNef for
48 h effectively reduced cholesterol efflux (Fig 3G) and abundance of both total and cell surface
ABCA1 (Fig 3H) in these cells relative to cells treated with exGFP. Cholesterol efflux from
exNef-treated human monocyte-derived macrophages (MDM) was also significantly reduced
(Fig 3I).
Expression of Nef may change the miRNA profile of exosomes, including abundance of
miRNAs involved in regulation of cholesterol metabolism [21, 22]. However, sequencing miR-
NAs in exosomes yielded only 4 miRNAs that were reliably different in Nef-containing exo-
somes (S1 Dataset, deposited to GEO, accession #GSE122657): hsa-mir-6882, hsa-mir-4786,
hsa-mir-1255a and hsa-mir-381. None of these miRNAs targets ABCA1 or has a known func-
tion in lipid metabolism.
Nef-containing exosomes reorganize lipid rafts
One consequence of inactivation of ABCA1 and suppression of cholesterol efflux is an increase
in the abundance of lipid rafts [23, 24]. Lipid rafts play a prominent role in pathogenesis of
many diseases, from cardiovascular disease and inflammation to dementia [25, 26]. We previ-
ously demonstrated that intracellular expression of Nef results in increased abundance of rafts
in macrophages [12]. Incubation of murine macrophages with exNef for 48 h resulted in a
control; C—Comparison of the effects of rNef (100 ng/ml) and exNef (0.4 ng/ml) on total and cell-surface ABCA1 after 48 h exposure (Western blot); D—
Comparison of the effects of rNef (100 ng/ml) and exNef (0.4 ng/ml) on cholesterol efflux from murine bone marrow derived macrophages after 48 h
exposure; �p<0.05 versus control; E—Comparison of the effects of rNef (100 ng/ml) and exNef (0.4 ng/ml) on total and cell-surface ABCA1 in murine
bone marrow derived macrophages after 48 h exposure (Western blot); F–The effect of silencing of Dynamin– 2 on the effect of exNef on the abundance of
total ABCA1 (Western blot). Mean ± SEM are shown on graphs (n = 4); G—Comparison of the effects of vehicle, exosomes produced by un-transfected
cells (exHEK), exGFP, and exNef (0.4 ng/ml) on cholesterol efflux after 48 h exposure; ��p<0.01 versus all other bars; H—Comparison of the effects of
vehicle, exosomes produced by un-transfected cells (exHEK), exGFP, and exNef (0.4 ng/ml) on total and cell-surface ABCA1 after 48 h exposure (Western
blot); I—Comparison of the effects of exosomes isolated from plasma of uninfected donors (exHIV-) and HIV-infected donors undergoing treatment with
ART (exHIV+) (4 μg/ml of exosomal protein, 48 h) on cholesterol efflux; ��p<0.01 versus exHIV-; J—Comparison of the effects of exosomes isolated from
plasma of uninfected donors (exHIV-) and HIV-infected donors undergoing treatment with ART (exHIV+) (4 μg/ml of exosomal protein, 48 h) on total
and cell-surface ABCA1 (Western blot).
https://doi.org/10.1371/journal.ppat.1007907.g002
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Fig 3. ExNef modify cellular cholesterol metabolism. A—Time-course of the effect of exNef (0.4 ng/ml) on the abundance of total and cell-surface ABCA1 (Western
blot); B—Abundance of Abca1 mRNA (qRT-PCR) after exposure to exGFP or exNef (0.4 ng/ml); ��p<0.01 versus exGFP; C–Average change in cholesterol efflux after
exposure of cells to exGFP or exNef (0.4 ng/ml) for 48 h (�p<0.05, n = 6); D—Cholesterol efflux after exposure of cells to exGFP or exNef (0.4 ng/ml) for 48 h (left) or
for 48 h followed by incubation without exosomes for another 48 h (right); #p<0.05 versus exNef 48 h, ��p<0.01 versus exGFP; E—Abundance of total ABCG1 and
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significant increase in the abundance of rafts determined by binding of cholera toxin subunit
B (CTB) and assessed by confocal microscopy (Fig 4A and 4B). We then labelled cells with
[3H]cholesterol under conditions allowing for equilibration of [3H]cholesterol in cellular cho-
lesterol pools, and isolated rafts by density gradient centrifugation of the plasma membrane
fraction. Distribution of [3H]cholesterol along the density gradient fractions is shown in Fig
4C, and distribution of flotillin-1 (marker of rafts) is shown in Fig 4D. We designated fractions
2–5 as rafts because they contained the highest concentrations of [3H]cholesterol and flotillin-
1 (Fig 4C and 4D). Raft fractions from cells treated with exNef contained more cholesterol and
more flotillin-1 than corresponding fractions from cells treated with exGFP (Fig 4C and 4D).
To estimate the concentration of ABCA1 per raft we analysed levels of ABCA1 in gels where
fractions were loaded at the same flotillin-1 concentration (Fig 4E). ABCA1 levels (Fig 4F) as
well as the ratios of ABCA1 to [3H]cholesterol (Fig 4G) and ABCA1 to flotillin-1 (Fig 4H) were
reduced in rafts of exNef-treated cells, indicating that these cells contain less ABCA1 per raft.
We next performed lipidomic analysis of isolated lipid rafts. Concentrations of lipids critical
for the raft structure are shown in Fig 4I; the results of analysis of over 700 lipid species in rafts
are presented in the S2 Dataset. When analysed relative to phosphatidylcholine level (i.e. on a
per raft basis), rafts isolated from cells treated with exNef contained higher concentration of
total ceramides and slightly lower concentration of total sphingomyelin when compared to
rafts isolated from cells treated with exGFP; there was no difference in raft cholesterol concen-
tration. Finally, we analysed rafts in exNef-treated human MDM from eight donors. The abun-
dance of rafts, measured by flow cytometry after CTB staining was significantly increased in
MDM treated with exNef relative to cells treated with control exosomes (p<0.03, n = 6) (Fig
4J). The abundance of rafts was also increased in CD4+ T-cells (p<0.05, n = 3), although the
effects were smaller, presumably because T-cells, compared to MDM, have lower abundance
of ABCA1 [12], the main target of exNef. Collectively, these findings indicate that exNef
increases the abundance of lipid rafts, changes lipid raft composition and reduces the abun-
dance of ABCA1 in rafts.
Nef-containing exosomes potentiate inflammation via re-localization of
TLR4 and TREM-1 to lipid rafts
Lipid rafts host many receptors involved in inflammatory responses and play a key role in reg-
ulation of inflammation [26]. To investigate if increased abundance of lipid rafts caused by
exNef affects innate inflammatory responses of macrophages, we tested the effect of exNef on
intracellular distribution of TLR4, a key inflammatory receptor, and TREM-1, an important
amplifier of innate immune responses [27, 28] and contributor to the foam cell formation and
atherogenesis [29]. Treatment of macrophages with exNef caused re-distribution of TREM-1
and TLR4 to the plasma membrane, dramatically increasing abundance of TLR4, TREM-1 and
rafts on the cell surface, and augmented co-localization of TLR4 and TREM-1 with rafts (Fig
5A and 5B). There was a considerable correlation between the abundance of rafts and TREM-1
at the plasma membrane (r = 0.73±0.09, p<0.001) and high level of co-localization between
CTB and TREM-1 (95±2.3%).
total and cell-surface ABCA1 after exposure of cells to exGFP or exNef (0.4 ng/ml) for 48 h or for 48 h followed by incubation without exosomes for another 48 h
(Western blot); F—Abundance of ABCA1 after co-cultivation of RAW264.7 cells with Nef or GFP producing HEK293 cells for 48 h (Western blot); G—Comparison of
the effects of exGFP and exNef (0.4 ng/ml) on cholesterol efflux from THP-1 human monocyte-macrophages after 48 h exposure; ��p<0.01 versus exGFP; H—
Comparison of the effects of exGFP and exNef (0.4 ng/ml) on the abundance of total and cell surface ABCA1 in THP-1 human monocyte-macrophages after 48 h
exposure (Western blot); I—Comparison of the effects of exGFP and exNef (0.4 ng/ml) on cholesterol efflux from human monocyte derived macrophages after 48 h
exposure. �p<0.05 versus exGFP. Mean ± SEM are shown on graphs.
https://doi.org/10.1371/journal.ppat.1007907.g003
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Fig 4. ExNef reorganize lipid rafts. A–The effect of exNef (0.4 ng/ml, 48 h) on the abundance of lipid rafts in RAW 264.7 cells (cholera toxin subunit B
(CTB) staining, confocal microscopy; Scale bars– 10 μm. B–Quantitation of the effect of exNef on the abundance of lipid rafts in RAW 264.7 cells by
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Next, we tested the effect of exNef on inflammatory responses by utilizing a bio-assay to
estimate cytokine production [30]. RAW264.7 cells were treated for 48 h with exNef or exGFP
and activated with LPS (24 h); medium was collected, exosomes removed by ultracentrifuga-
tion, and supernatant used to treat murine vascular endothelial cells stably expressing lucifer-
ase under the VCAM-1 promoter (SVEG/VCAM). Treatment of RAW 264.7 cells with exNef
resulted in an increased release of factors activating VCAM-1 in endothelial cells (Fig 5C).
Consistent with findings in murine cells, treatment of human MDM with exNef for 48 h
caused a significant increase of secretion of TNFα (Fig 5D) and IL-6 (Fig 5E) after stimulation
with LPS; unstimulated secretion of both TNFα and IL-6 in these cells was very low and unaf-
fected by exNef (Fig 5D and 5E).
To confirm that redistribution and activation of TLR4 results in downstream inflammatory
responses, we tested the effect of exNef on phosphorylation of ERK1/2. While there was no dif-
ference in total ERK1/2 abundance between exGFP and exNef treated cells, the abundance of
phosphorylated (active) ERK1/2, and consequently the ratio of phosphorylated to total ERK1/
2, were significantly higher in cells treated with exNef compared to cells treated with exGFP
(Fig 5F and 5G). Next, we tested the effect of exNef on activation of NLRP3 inflammasome. In
these experiments formation of inflammasome in BMDM isolated from C57Bl/6 mice was
primed by treatment with LPS and then the release of interleukin IL-1β was induced by Nigeri-
cin. The amount of IL-1β released from cells pre-treated with exNef was statistically signifi-
cantly higher than that from cells pre-treated with exGFP (Fig 5H). Furthermore, pre-
treatment with exNef increased cleavage of pro-caspase-1 with release of proteolytically
cleaved p10 form to the cell culture medium (Fig 5I). These experiments indicate that exNef
potentiates a signalling cascade originating from TLR4 and resulting in NLRP3 inflammasome
activation and release of IL-1β.
Finally, we assessed the possible toxicity of exNef. Neither exGFP nor exNef caused an
appreciable necrosis or apoptosis in murine macrophages (Fig 5J).
Nef-containing exosomes regulate rafts and inflammation via Cdc42 axis
To gain further insight into the mechanism of the effect of Nef on the abundance of lipid rafts
and inflammation, we tested a hypothesis originally proposed by Nofer et al. [31, 32] and vali-
dated in later studies [33], that a reciprocal connection between ABCA1 abundance and lipid
rafts is maintained through activation of the small GTPase Cdc42, polymerization of actin, and
subsequent negative regulation of raft abundance [34]. Thereby, by reducing the abundance of
ABCA1, exNef may dampen the Cdc42 activation, reduce actin polymerization, and increase
lipid raft abundance [30, 34]. Indeed, activation of Cdc42 by bradykinin was impaired in cells
treated with exNef for 48 h (Fig 6A), whereas the overall abundance of Cdc42 was not affected
(Fig 6B). The abundance of filamentous actin (F-actin) was reduced dramatically in cells
treated with exNef (Fig 6C and 6D). To overcome an impairment in Cdc42 activation caused
by exNef, we transfected cells with constitutively active mutant of Cdc42, Cdc42(Q61L)-GFP
[35]. Overexpression of Cdc42(Q61L)-GFP reduced lipid raft abundance in macrophages; the
confocal microscopy (CTB staining); ��p<0.01 versus exGFP; C—Amount of [3H]cholesterol in fractions of density gradient centrifugation (from top to
bottom) of plasma membranes from exGFP or exNef treated RAW 264.7 cells. D–Abundance flotillin-1 in fractions of density gradient centrifugation
(from top to bottom) of plasma membranes from exGFP or exNef treated RAW 264.7 cells (Western blot). E—Abundance of ABCA1 in raft fractions from
exGFP or exNef treated RAW 264.7 cells (Western blot). F–Quantitation (densitimetry) of cummulative abundance of ABCA1 in raft fractions. G–Ratio of
ABCA1 abundance to [3H]cholesterol counts in raft fractions; ��p<0.01 versus exGFP; H–Ratio of abundancies of ABCA1 to flotillin-1 in raft fractions. I–
Concentration of cholesterol, total ceramides and total sphyigomielin in isolated lipid rafts; ���p<0.001 versus exGFP J—Quantitation of the effect of exNef
on the abundance of lipid rafts in human monocyte derived macrophages by flow cytometry (CTB staining); box plot of n = 6 is shown, �p<0.05. K—
Quantitation of the effect of exNef on the abundance of lipid rafts in CD4+ T-cells by flow cytometry (CTB staining); n = 3, �p<0.05.
https://doi.org/10.1371/journal.ppat.1007907.g004
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Fig 5. ExNef potentiate inflammatory signalling cascade via re-localization of TLR4 and TREM-1 to lipid rafts. A–The effect of exNef (0.4 ng/
ml, 48h) on the abundance of lipid rafts and re-localization of TLR4 and TREM-1 to the plasma membrane in RAW264.7 macrophages. Left
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abundance of rafts in cells treated with exNef was reduced below their level in cells treated
with exGFP (Fig 6E and 6F).
Next, we tested the effects of exNef on distribution of TREM-1 and TLR4 in RAW 264.7
macrophages after transfecting cells with Cdc42(Q61L)-GFP. As expected, in mock-trans-
fected control cells treated with exNef (cells negative for GFP) a considerable proportion of
TREM-1 (Fig 6G) and TLR4 (Fig 6H) was localized to the plasma membrane. However, when
Cdc42(Q61L)-GFP was overexpressed (cells positive for GFP), The abundance of TREM-1
and TLR4 on the plasma membrane was significantly reduced (Fig 6G and 6H). Furthermore,
while secretion of TNFα after stimulation of cells with LPS was higher after treatment of cells
with exNef, in cells transfected with Cdc42(Q61L)-GFP secretion of TNFα was reduced to the
level of control (exGFP-treated) Cdc42(Q61L) expressing cells (Fig 6I). Reduction of TNFα
secretion in exNef treated cells transfected with Cdc42 (Q61L)-GFP was accompanied with
reduction in phosphorylation of ERK1/2, total ERK1/2 was not affected (Fig 6J). Thus, it
appears that exNef, likely through its effects on ABCA1, impairs activation of Cdc42 leading to
reduction of actin polymerization, increased abundance or lipid rafts and potentiated inflam-
matory response.
Nef-containing exosomes modify lipid rafts and potentiate inflammation
in vivo
To confirm our findings in an in vivo setting, we injected exNef or exGFP intravenously into
C57Bl/6 mice. Exosomes (2 μg protein per injection) were injected 3 times per week for 2
weeks; blood and tissues were then collected for analysis. The proportions of monocytes and
in particular of a Ly6-Clo monocyte subset (patrolling monocytes) were elevated in mice
treated with exNef (Fig 7A). The abundance of rafts in total monocytes and in Ly6-Chi (inflam-
matory monocytes) and Ly6-Clo subsets was measured by flow cytometry. We found increased
abundance of rafts in these cells after treatment of animals with exNef as compared to treat-
ment with exGFP (Fig 7B). This was accompanied with elevation of the plasma levels of IL-6
(Fig 7C) and TNFα (Fig 7D). Next, we analysed the effect of exNef on ABCA1 abundance in
the liver and peritoneal macrophages. The abundance of ABCA1 in liver and peritoneal mac-
rophages was reduced by 30% and 65%, respectively, in mice treated with exNef when com-
pared to treatment with exGFP (Fig 7E and 7F). There was no effect of exNef infusion on
plasma total cholesterol or triglyceride content, however, there was a borderline reduction
(20%, p = 0.05) in plasma HDL cholesterol content (Fig 7G–7I). We next performed lipido-
mics analysis of plasma samples (S3 Dataset). We found no difference in the abundance of
lipid species between plasma of mice injected with exNef versus exGFP-injected mice. Thus,
the main effect of exNef in vivo, at least in the short term, was on cellular, rather than systemic
lipid metabolism.
column, CTB staining; second column, anti-TREM-1 staining; third column anti-TLR4 staining; fourth column–merge TREM-1/rafts, right
column–merge TLR4/rafts. Scale bars 10 μm; B–Quantitation of the effect of exNef (0.4 ng/ml, 48 h) on the abundance of lipid rafts, TREM-1 and
TRL4 at the plasma membrane. Mean ± SEM are shown; ��p<0.01, ���p<0.001 versus exGFP; C–Bio-assay for inflammatory cytokines secreted by
macrophages treated with exNef (0.4 ng/ml, 48 h) after stimulation with LPS (100 ng/ml of LPS for 18 h). Luminescence produced by SVEG/
VCAM endothelial cells (stably transfected with luciferase under VCAM-1 promoter) is shown (see Methods for details). ��p<0.001. D–The effect
of exNef on TNFα secretion by human monocyte derived macrophages with or without stimulation with 1 ng/ml of LPS for 24 h; �p<0.05. E–The
effect of exNef on IL-6 secretion by human monocyte derived macrophages with or without stimulation with 1 ng/ml of LPS for 24 h; �p<0.05. F–
The effect of exNef (0.4 ng/ml, 48 h) on the abundance of total and phosphorylated ERK1/2 in RAW 264.7 macrophages (Western blot); G–Ratio of
phosphorylated to total ERK1/2 (Western blots, n = 3, �p<0.05); H- Release of Il-1β from BMDM pre-treated with exNef (0.4 ng/ml, 48 h) and
treated with LPS (100 ng/ml, 4 h)) and Nigericin (5μM, 3 h). Control cells were treated with exGFP; n = 4, ���p<0.001. I–The effect of exNef (0.4
ng/ml, 48 h) on the abundance of pro-caspase-1 in the BMDM cell lysate and of the cleaved p10 form immunoprecipitated from the cell culture
medium (Western blot); J–The effect of exNef (0.4 ng/ml, 48 h) on apoptosis and necrosis in RAW 264.7 macrophages (TUNEL assay).
https://doi.org/10.1371/journal.ppat.1007907.g005
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Fig 6. ExNef reorganize lipid rafts and potentiate inflammation via the ABCA1-Cdc42-actin axis. A—The effect of exNef (0.4 ng/
ml) on activation of Cdc42 by bradykinin (BRK, 100 ng/ml). Cdc42 activity was assessed by G-LISA, the assay detects concentration of
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Nef-containing exosomes from HIV-infected cells and isolated from
plasma of HIV-infected subjects modify lipid rafts and potentiate
inflammation
To further elucidate effects of Nef in the context of HIV infection, we isolated exosomes pro-
duced by human MDM either uninfected (Mock) or infected with WT HIV (exHIV) or Nef-
deficient HIV (exΔNefHIV). MDM (from 6 different donors) were incubated with isolated
exosomes equalized by RT activity in the presence of fusion inhibitor T-20 (to prevent infec-
tion by the virus present in exosome preparation) for 48 h; exosomes from uninfected cells
were added at the exosome protein concentration equal to exHIV. The abundance of lipid
rafts on cells (Fig 8A) as well as the amounts of TNFα and IL-6 secreted into the medium after
stimulation with 1 ng/ml of LPS (Fig 8B and 8C) were significantly elevated in cells treated
with exHIV as compared to cells treated with exosomes from uninfected cells or exΔNefHIV.
Next, we took advantage of availability of plasma from patients infected with Nef-deficient
strain of HIV (ΔNef-HIV) [22] and compared the effects of exosomes isolated from plasma of
these patients and patients infected with WT HIV or uninfected subjects. Plasma samples
from subjects from each of the three groups (6 subjects in ΔNef-HIV infected group and 4 sub-
jects in each of the two other groups) were pooled, exosomes isolated and tested in the experi-
ments with RAW 264.7 murine macrophages. Murine macrophages could not be infected with
HIV that might be present in the exosome preparations, so no fusion inhibitor was necessary.
Abundance of rafts (Fig 8D and 8E), the abundance of TLR4 in the cells (Fig 8F and 8G) or in
the lipid rafts (Fig 8F and 8H), and secretion of TNFα (Fig 8J) and IL-6 (Fig 8I) were similarly
elevated in cells incubated for 48 h with exosomes produced by Nef-expressing HEK293 cells
(exNef) or isolated from plasma of WT HIV infected subjects (ex(WT-HIV)) when compared
to cells treated with the same concentration of exosomes produced by GFP-expressing
HEK293 cells (exGFP) or isolated from plasma of ΔNef-HIV infected (ex(ΔNef-HIV)) or unin-
fected (ex(HIV-)) subjects. Concentration of Nef in ex(WT-HIV) was estimated as 0.1 ng Nef
per 1 μg of exosomal protein (Fig 8K). These findings demonstrate that Nef-containing extra-
cellular vesicles produced by HIV-infected cells modify lipid rafts and induce pro-inflamma-
tory response.
Discussion
In this study, we investigated how exosomes containing the HIV protein Nef alter cellular
functions and cause inflammation associated with HIV infection. The main findings of this
study can be summarized as follows: (i) Nef-containing exosomes (exNef) rapidly and effec-
tively deliver Nef to macrophages; (ii) exNef affect cellular cholesterol metabolism (inhibit the
GTP-bound (active) Cdc42. Mean ± SEM is shown; �p<0.05 versus non-activated cells; #p<0.01 versus activated cells treated with
exGFP; (n = 4); B–The effect of exNef (0.4 ng/ml) on the abundance of total Cdc42 (Western blot). C–The effect of exNef (0.4 ng/ml, 48
h) on the abundance of F-actin (Alexa Fluor 488 Phalloidin staining); Scale bars– 10 μm. D–Quantitation of the effect of exNef on the
abundance of F-actin. Mean ± SEM is shown; ��p<0.01; E–The effect of transfection of cells with with GFP (top row) or Cdc42(Q61L)-
GFP (bottom row) before exposure to exNef (0.4 ng/ml, 24 h) on the abundance of rafts (CTB staining, confocal microscopy); Scale
bars– 10 μm. F–Quantitation of the effect of transfection of cells with GFP or Cdc42(Q61L)-GFP before exposure to exNef (0.4 ng/ml,
48 h) on the abundance of rafts (CTB staining, confocal microscopy); ���p<0.001 versus GFP-transfected cells; #p<0.05 versus
corresponding exGFP-treated cells. G–The effect of transfection of cells with with Cdc42(Q61L)-GFP before exposure to exNef (0.4 ng/
ml, 24 h) on the localization of TREM-1; left panel, Cdc42-GFP (transfected cells), middle panel, TREM-1, right panel, merge. Scale bars
10 μm; H–The effect of transfection of cells with with Cdc42(Q61L)-GFP before exposure to exNef (0.4 ng/ml, 24 h) on the localization
of TLR4; left panel, Cdc42-GFP (transfected cells), middle panel, TLR4, right panel, merge. Scale bars 10 μm. I—The effect of
transfection of cells with with Cdc42(Q61L)-GFP before exposure to exNef (0.4 ng/ml, 48 h) and stimulation with LPS (100 ng/ml, 18 h)
on secretion of TNFα. Means ±SEM is shown; ��p<0.01 versus exGFP. J—The effect of transfection of cells with Cdc42(Q61L) on the
abundance of phosphorylated ERK1/2 in RAW 264.7 macrophages treated with exNef (0.4 ng/ml, 48 h) (Western blot).
https://doi.org/10.1371/journal.ppat.1007907.g006
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Fig 7. ExNef modify lipid rafts and potentiate inflammation in vivo. C57BL/6 mice were administered either exNef or exGFP (2μg, I.V.) 3 times a
week, for a period of 2 weeks. A–Proportion of monocytes in blood (n = 9 per group), �p<0.05 versus exGFP; B—Flow cytometry analysis of raft
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abundance of ABCA1 and reduce cholesterol efflux) similar to the effect of HIV infection or
recombinant Nef, but the effect of exNef was several orders of magnitude more potent than of
recombinant Nef; (iii) exNef increase the abundance of lipid rafts through impairment of acti-
vation of Cdc42 followed by re-organization of actin cytoskeleton; (iv) exNef potentiate
inflammatory responses in vitro and in vivo, likely through the effects on lipid rafts followed by
activation of ERK1/2, activation of NLRP3 inflammasome and secretion of pro-inflammatory
cytokines; (v) injection of exNef in vivo causes monocytosis, increases the abundance of rafts
in monocytes, reduces ABCA1 abundance in several tissues, increases inflammatory cytokine
production and causes hyperalphalipoproteinemia; (vi) ex vivo, exosomes isolated from HIV-
infected cells or from plasma of HIV-infected subjects, but not from ΔNef-HIV infected cells
or subjects, increase lipid rafts, TLR4 recruitment to rafts and inflammatory response in mac-
rophages. The fact that Nef-containing exosomes produced by Nef-transfected HEK293 cells,
HIV-infected MDMs and isolated from plasma of HIV-infected donors had similar effects on
lipid rafts independently of the source, and exosomes not containing Nef did not show these
effects, is a strong indication that the cause of these effects is in fact Nef, as opposed to other
exosome constituents.
We propose the following mechanism of the effect of Nef on inflammation (Fig 9). 1. Nef
released in exosomes from HIV–infected cells is taken up by bystander cells where it reduces
the amount of ABCA1 by previously described mechanisms: displacing ABCA1 from rafts
with subsequent degradation of ABCA1 [12] and preventing interaction of newly synthesized
ABCA1 with calnexin, also followed by its degradation [36]. 2. Reduction of ABCA1 inhibits
activation of Cdc42, which in turn decreases formation of filamentous actin enhancing forma-
tion of lipid rafts [34]. Several studies reported activation of Cdc42 by Nef [37, 38]. However,
these studies investigated the effects of intracellularly produced Nef in T-lymphocytes, cells
that express very little ABCA1 [12], and this activity of Nef may be independent to that in our
study. 3. Increase in lipid raft abundance leads to recruitment into rafts of TREM-1 and TLR4,
leading to the enhanced activation of TLR4, phosphorylation of ERK1/2, activation of NLRP3
inflammasome and augmented secretion of pro-inflammatory cytokines.
These findings are consistent with a suggestion that Nef-containing exosomes constitute an
important factor in pathogenesis of several metabolic co-morbidities of HIV disease. Nef is dis-
pensable for HIV replication in vitro [39], but patients infected with Nef-deficient HIV strain
develop very mild, if any, HIV disease [40], implying that the main pathogenic function of Nef
is systemic rather than intracellular [16]. Recombinant Nef injected into apoe-/- mice fed a
high-fat diet enhanced atherosclerosis and caused hypoalphalipoproteinemia and hypertrigly-
ceridemia characteristic to HIV infection [41]. We propose that Nef creates a metabolic milieu
that is favourable for HIV replication at the same time causes metabolic complications in the
host. Cholesterol and lipid rafts play important role in HIV biology (for review see [10]),
impairment of cholesterol metabolism and overabundance of rafts would benefit the virus, but
at the same time may exacerbate co-morbidities that have impairment of cholesterol metabo-
lism and inflammation as elements of their pathogenesis. These considerations firstly apply to
atherosclerosis, a pathology responsible for a range of cardiovascular co-morbidities of HIV
disease. Reduction in ABCA1 and consequently of cholesterol efflux, as well as increased abun-
dance of TREM-1 in rafts, are recognized factors promoting accumulation of cholesterol in
abundance (CTB binding) in blood monocytes (n = 9 per group); �p<0.05 versus exGFP; C–Plasma IL-6 content (n = 8 per group); ��p<0.01 versus
exGFP; D–Plasma TNFα content (n = 8 per group); ��p<0.01 versus exGFP; E—ABCA1 abundance in the liver homogenate determined by Western blot
(n = 8 per group); �p<0.05 versus exGFP; F—ABCA1 abundance in the peritoneal macrophages determined by Western blot (n = 6 per group); ��p<0.01
versus exGFP; G–Plasma total cholesterol content (n = 8 per group); H–Plasma HDL cholesterol content (n = 8 per group); #p = 0.05 versus exGFP, I–
Plasma triglyceride content (n = 8 per group). Mean ± SEM are shown.
https://doi.org/10.1371/journal.ppat.1007907.g007
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Fig 8. Exosomes from HIV-infected cells and plasma of HIV-infected subjects modify rafts and potentiate inflammation. A–
The effect of exosomes produced by human monocyte derived macrophages (MDM) infected with HIV (exHIV) or ΔNefHIV
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(exΔNefHIV) on the abundance of rafts in MDM measured with flow cytometry; 48 h incubation; box plot of n = 6 (six separate
experiments with MDM from 6 different donors) is shown; �p<0.05 versus both Mock and exΔNefHIV; B–The effect of exosomes
produced by human monocyte derived macrophages infected with HIV (exHIV) or ΔNefHIV (exΔNefHIV) on secretion of TNFα
by MDM over 48 h; box plot of n = 6 is shown; ��p<0.01 versus both Mock and exΔNefHIV; C–The effect of exosomes produced
by human monocyte derived macrophages infected with HIV (exHIV) or ΔNefHIV (exΔNefHIV) on the secretion of IL-6 over 48
h incubation. N = 6, �p<0.05 versus both Mock and exΔNefHIV; D–The effect of exNef, exGFP and exosomes isolated from
plasma of subjects infected with HIV (ex(WT-HIV)) or infected with Nef-deficient strain of HIV (ex(ΔNef-HIV)) or uninfected
(ex(HIV-)) (15 μg/ml of exosomal protein except when 4 μg/ml is indicated, 48h) on the abundance of lipid rafts in RAW264.7
macrophages. Scale bars 10 μm; E–Quantitation of the effect of exosomes (as in A)) on the abundance of lipid rafts. Mean ± SEM
are shown; ��p<0.01 versus exGFP and ex(HIV-). F–The effect of exNef, exGFP and exosomes isolated from plasma of subjects
infected with HIV (ex(WT-HIV)) or infected with Nef-deficient strain of HIV (ex(ΔNef-HIV)) or uninfected (ex(HIV-)) (15 μg/
ml of exosomal protein except when 4 μg/ml is indicated, 48h) on the abundance and localization of lipid rafts (red) and TLR4
(green) in RAW264.7 macrophages. Scale bars 10 μm; G–Quantitation of the effect of exosomes (as in B)) on the total abundance
of TLR4 in cells. Mean ± SEM are shown; �p<0.05, ��p<0.01 versus exGFP and ex(HIV-). H–Quantitation of the effect of
exosomes (as in B)) on the abundance of TLR4 in lipid raft regions. Mean ± SEM are shown; ��p<0.01 versus exGFP and ex
(HIV-/-); J–The effect of exNef, exGFP and exosomes isolated from plasma of subjects infected with HIV (ex(WT-HIV)) or
infected with Nef-deficient strain of HIV (ex(ΔNef-HIV)) or uninfected (ex(HIV-)) (15 μg/ml of exosomal protein except when
4 μg/ml is indicated, 48h) and stimulation with 100 ng/ml LPS on secretion of TNFα by RAW264.7 macrophages over 1 h;
Mean ± SEM are shown; ��p<0.01, ���p<0.001; I–The effect of exNef, exGFP and exosomes isolated from plasma of subjects
infected with HIV (ex(WT-HIV)) or infected with Nef-deficient strain of HIV (ex(ΔNef-HIV)) or uninfected (ex(HIV-)) (15 μg/
ml of exosomal protein except when 4 μg/ml is indicated, 48h) and stimulation with 100 ng/ml LPS on secretion of IL-6 by
RAW264.7 macrophages over 1 h; Mean ± SEM are shown; ��p<0.01, ���p<0.001; K—Western blot for the indicated amounts of
rNef and ex(WT-HIV) (μg of exosomal protein).
https://doi.org/10.1371/journal.ppat.1007907.g008
Fig 9. The proposed mechanism of the effect of exNef on inflammation. Nef released in exosomes from HIV–infected
cells is taken up by bystander cells where it reduces the amount of ABCA1 by previously described mechanisms:
displacement of ABCA1 from rafts with subsequent degradation of ABCA1 and preventing interaction of newly
synthesized ABCA1 with calnexin, also followed by its degradation. Reduction of ABCA1 inhibits activation of Cdc42,
which in turn decreases formation of filamentous actin enhancing formation of lipid rafts. Increase in lipid raft
abundance leads to recruitment into rafts of TREM-1 and TLR4, leading to the activation of TLR4, phosphorylation of
ERK1/2, activation of inflammasomes and stimulation of secretion of pro-inflammatory cytokines.
https://doi.org/10.1371/journal.ppat.1007907.g009
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macrophages and inflammation [29, 42], two key elements in pathogenesis of atherosclerosis.
Given that Nef-containing exosomes can be released from infected cells and have a consider-
able potency to affect cholesterol metabolism in uninfected cells, they can potentiate choles-
terol accumulation and inflammatory response not only in HIV-infected, but in all
macrophages, contributing significantly to the risk of atherosclerosis. Moreover, the effects of
Nef on cholesterol metabolism in other cells involved in pathogenesis of atherosclerosis that
cannot be infected with HIV, such as endothelial and smooth muscle cells, may also contribute
to this co-morbidity.
Another co-morbidity likely related to the effects of Nef on cholesterol metabolism is HIV-
associated neurocognitive disorder (HAND). HIV infects macrophages, glial cells and astro-
cytes, but does not infect neurons, which play a key role in neurodegenerative disorders, nor
endothelial cells, responsible for the integrity of blood-brain barrier [43]. Recently, Raymond
and Khan [9, 17] in a series of elegant studies demonstrated the role of Nef-containing exo-
somes in pathogenesis of HAND, however, direct toxicity of Nef was suggested as a putative
mechanism. The role of cholesterol metabolism and of lipid rafts in pathogenesis of neurode-
generative diseases is firmly established [25, 44], so the effects of Nef, through regulating lipid
rafts directly and/or through potentiating inflammation, may contribute, if not drive, neurode-
generation caused by HIV infection.
Pathogenesis of several other co-morbidities of HIV infection may also involve impairment
of cholesterol metabolism by Nef. Haematological co-morbidities of HIV infection were, on
the one hand, attributed to the action of Nef [45], and, on the other hand, have cholesterol
metabolism in the centre of their pathogenesis [46]. The role of ABCA1 and cholesterol metab-
olism in pathogenesis of diabetes, a frequent co-morbidity of HIV infection [47], is also well
established [48]. The effects of Nef on these and other HIV co-morbidities may be direct, tar-
geting cholesterol metabolism-related elements of their pathogenesis, but also indirect,
through potentiating inflammation, which in turn has impairment of cholesterol metabolism
and enhanced formation of lipid rafts among the key elements of pathogenesis [26].
Nef-containing exosomes were found in plasma of patients receiving antiretroviral treat-
ment and having no detectable viral load [9, 17, 49]. Most likely, the origin of these exosomes
is a small number of HIV infected cells residing in HIV reservoirs [5, 50]. Secretion of exNef
from infected cells can occur despite effective HIV suppression: current antiretroviral drugs
affect every step of the HIV life cycle except transcription and translation, thereby allowing
production and release of viral components such as Nef [7, 8]. Interestingly, Nef itself is a
potent activator of microvesicle exocytosis, and mechanism of release of Nef-containing exo-
somes from infected cells has been recently described [9, 51]. Delivery by exosomes, however,
is not the only mechanism behind the bystander effects of Nef: transfer of Nef to uninfected
cells by trogocytosis has been recently demonstrated [51].
It must, however, be recognized that the broad clinical relevance of our findings remains
unclear. While the results of the experiments on the effects of exosomes from pooled plasma
samples of few HIV-infected subjects are consistent with the proposed mechanisms, they pro-
vide only limited evidence for the importance of these mechanisms in clinical setting, espe-
cially in the context of ART treatment. A clinical study relating clinical endpoints to biological
activity of exosomes isolated from plasma of HIV-infected subjects treated with different regi-
mens of ART and with different levels of exNef in their blood is required to convincingly
address this question.
In conclusion, Nef released from HIV-infected cells in exosomes may be responsible for
systemic impairment of cholesterol metabolism in cells not infected by HIV, causing inflam-
mation and contributing to multiple co-morbidities of HIV disease.
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Methods
Cells
Mouse macrophage cells RAW264.7 (ATCC, Manassas, VA) were grown in RPMI-1640
medium supplemented with 10% foetal bovine serum (FBS) (Gibco).
Human monocyte cells THP-1 (ATCC, Manassas, VA) were grown in RPMI-1640 medium
supplemented with 10% FBS. To differentiate cells into macrophages Phorbol Myristate Ace-
tate (PMA) was added to the media at concentration 100 ng/ml for 72 hours.
Bone marrow derived macrophages (BMDM) were isolated from tibia and femur bones of 6–8
week-old C57Bl/6 male mice as described by Shrestha et al [52]. In brief, bone marrow was flushed
out from bones with IMDM containing 10% FBS. Cells were spun, pellet washed and incubated
for 10 min in red blood cell lysis buffer (155 mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA, pH
7.3). Cells were centrifuged and pellet was resuspended in IMDM containing 10% FBS and 15% of
L929 cell conditioned media. Cells were plated in Petri dishes (BD) and cultured for 5 days.
Human monocyte-derived macrophages were prepared from normolipidemic donor blood
(obtained from New York Blood Bank) by plastic adherence and differentiated in the presence
of 50 ng/ml M-CSF for 7 days.
Human embryonic kidney cells 293T (HEK293T, ATCC, Manassas, VA) were grown in
DMEM supplemented with 10% exosome-depleted FBS.
SVEC4/VCAM-1 cells (a kind gift or Dr Alan Remaley, NHLBI) were grown in RPMI-1640
medium supplemented with 10% FBS.
Antibodies
Primary antibodies used for the Western blotting analysis were:
1. Monoclonal mouse anti-Abca1 antibody (Abcam, #ab18180). This antibody was character-
ized in our previous studies [30, 53].
2. Monoclonal mouse anti-α1 sodium potassium ATPase antibody (Abcam, #ab7671). This
antibody was characterized in our previous studies [53].
3. Monoclonal mouse anti-Cdc42 antibody (BD Transduction Laboratories, #610929). This
antibody was characterized in our previous studies [53].
4. Monoclonal mouse anti-dynamin-2 antibody (BD Transduction Laboratories, #610248).
This antibody was characterized in our previous studies [53].
5. Monoclonal mouse anti-Alix antibody (Novus biologicals, NB100-65678).
6. Monoclonal mouse anti-Nef antibody was obtained through the NIH AIDS Reagent Pro-
gram, Division of AIDS, NIAID, NIH: Anti-HIV-1 SF2 Nef Monoclonal (EH1, #3689).
7. Monoclonal mouse anti ERK1/2 antibodies (Merck Millipore, #05–1152)
8. Monoclonal rabbit anti Phospho-p44/42 MAPK (Erk1/2), (Cell Signalling Technology,
#4370)
9. Anti-pro Caspase-1 + p10 + p12 antibody, (Abcam, #ab179515)
Secondary antibodies used for the Western blotting analysis were:
1. Horseradish peroxidase-conjugated anti-mouse IgG antibody, (Sigma-Aldrich, #A9044).
2. Biotin conjugated anti-mouse IgG antibody (Sigma-Aldrich, #B8520).
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3. Horseradish peroxidise-conjugated anti-rabbit IgG antibody (Cell Signalling Technology,
#7074S).
4. VeriBlot for IP Detection Reagent (HRP) (Abcam, #ab131366)
Primary antibodies used for confocal microscopy were:
1. Polyclonal anti- ABCA1 antibody (Novus Biologicals, #NB400-105). This antibody was
characterized in our previous studies [12, 53].
2. Monoclonal anti-ABCA1 antibody (Abcam, #ab18180). This antibody was used in co-loca-
lisation images of ABCA1 and rafts.
3. Monoclonal rat anti-TREM1 antibody (R&D Systems, #MAB1187)
4. Monoclonal mouse anti-TLR4 antibody (Abcam, #22048)
Secondary antibodies used for confocal microscopy were:
1. AlexaFluor 633-labelled anti-rabbit IgG antibody (Invitrogen, #A-21070).
2. AlexaFluor 546-labeled anti-mouse IgG antibody (Invitrogen, A111030)
3. AlexaFluor 546-labeled anti-rat IgG antibody (Invitrogen, A11081)
Transfections. RAW264.7 macrophages were transfected with constitutively active Cdc42
plasmid (pcDNA3-EGFP-Cdc42(Q61L), Addgene plasmid # 12600) [35]. Briefly, cells were
seeded in antibiotic-free RPMI-1640 media supplemented with 10% FBS. Transfections were
performed 18 h later when cells were 70–80% confluent. Transfections were done using Lipo-
fectamine LTX with Plus Reagent (Invitrogen) according to manufacturer’s protocol.
HEK293 cells were transfected either with HIV-1 NefSF2WT (kind gift of Dr Matija Peter-
lin) or control pEGFP- C1 plasmid (Clontech) using Lipofectamine LTX with Plus Reagent
(Invitrogen) according to manufacturer’s protocol. Average transfection efficiency was 80%.
Exosome isolation and purification
Transfected HEK293 cells were grown in DMEM supplemented with 10% heat-inactivated exo-
some-depleted FBS. Exosome-depleted FBS was prepared by ultracentrifugation for 2 h at 4˚C,
100,000 x g using Beckman Coulter Optima MAX-TL centrifuge. Forty eight hours post transfec-
tion medium from cell culture was collected and exosomes were isolated as described by Rider et al
[54]. Briefly, exosome-containing medium was pre-cleared from cellular debris by low speed centri-
fugation (2000 x g) for 30 min, mixed in equal volume of 16% Polyethylene glycol/1M NaCl (Sigma
Aldrich), incubated at 4˚C for 18 h on a rotating platform and centrifuged at 4˚C, 4000 x g for 60
min. Pellet was collected, resuspended in PBS and spun again for 2 h at 4˚C, 100,000 x g. Final pellet
was resuspended in PBS, aliquoted and frozen at -80˚C. Total protein content in exosome samples
was estimated by Bradford assay after dilution in RIPA buffer and boiling for 3 minutes.
In some experiments exosomes were labelled with PKH67 Green Fluorescent Dye. PKH67
Green Fluorescent Cell Linker Kit for General Cell Membrane Labelling (Sigma-Aldrich) was
used according to the manufacturer’s protocol, except that washing procedure was modified
according to La¨sser et al [55]. After incubation with stain, exosomes were transferred to 300
kDa Vivaspin filters (Sartorius Stedim Biotech GmbH, Gottingen, Germany) and centrifuged
at 4,000 × g. Samples were washed at least 3 times with 5 ml of PBS until there was no fluores-
cence in the wash-through before being transferred to new 300 kDa Vivaspin filters and
washed twice with serum free RPMI.
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Electron microscopy and assessment of exosome size
Isolated exosomes were resuspended in 0.1 M sodium cacodylate buffer pH 7.2 to a required
concentration, and 5μl was placed onto formvar carbon coated 200 mesh copper grids (Elec-
tron Microscopy Sciences, Hatfield, PA) for 1 min and removed. The grids were then fixed
with 4% glutaraldehyde in sodium cacodylate buffer for 5 min and washed. They were stained
with 2% aqueous uranyl acetate for 1 min, and imaged with a FEI Talos F200X Transmission
Electron Microscope (Brno, Czech Republic) at 80 KV. The size of exosomes was ascertained
from electron microscopy images using Image J software and calibrated magnification bars on
the images.
Experiments with exosomes from HIV-infected cells
To generate exosomes from HIV-infected cells, monocyte-derived macrophages were infected
with Nef-positive and Nef-negative CCR5-tropic viruses (2x106 cpm of RT activity per 106 cells)
pBRNL4.3_92BR020.4(R5)nef+_IRES_GFP and pBRNL4.3_92BR020.4(R5)nef-_IRES_GFP
[56], respectively. Virus replication was followed by assaying reverse transcriptase activity in
culture supernatants, and when it reached 1,200 cpm/μl (12 days post infection in culture
infected with Nef-positive virus and 15 days post infection in culture infected with Nef-negative
virus) the culture supernatants were collected and extracellular vesicles were isolated as
described above.
Preparations of extracellular vesicles equalized by RT activity were added for 48 h to MDM
from 6 different donors in the presence of fusion inhibitor T20 (1 μg/ml). At the end of incu-
bation, cells were separated into two aliquots: one was analyzed for lipid rafts by staining with
fluorescently-tagged CTB and flow cytometry, another was stimulated with 1 ng/ml of LPS
and after 24 h was analyzed for production of IL-6 and TNFα as described below.
Cell surface protein biotinylation and Western blots
Cells were lysed with RIPA buffer, protein concentration in lysates estimated by Bradford
assay followed by SDS-PAGE and transfer of proteins to PVDF membrane. To assess abun-
dance of the cell-surface ABCA1, cells were washed three times with ice cold PBS and biotiny-
lated with Sulfo-NHS-SS-Biotin as described previously [12, 53]. Biotinylation reaction was
quenched by washing cells twice with 50 mM Tris, 150 mM NaCl, 0.1 mM EDTA. Cells were
lysed with RIPA buffer and biotinylated proteins were purified by incubating for 2 h at 4˚C
with High Performance Streptavidin Sepharose (Thermo Fisher Scientific). Bound biotinylated
proteins were removed from resin by 30 min incubation in loading buffer supplemented with
50 mM DTT at 50˚C and centrifugation. Supernatants were subjected to SDS-PAGE, proteins
were transferred to PVDF membrane and probed.
Cholesterol efflux
Cholesterol efflux was measured as described previously [53, 57]. In brief, cells were labelled
by incubation in serum-containing medium supplemented with [3H]cholesterol (75 kBq/ml,
American Radiolabelled Chemicals for 48 h. Cells were washed and incubated for 18 h in
serum-free medium in the presence of LXR agonist TO-901317 (final concentration, 4 μM).
Human apoA-I (kind gift from CSL Behring) was added to the final concentration of 30 μg/ml
and cells were incubated for 2 h at 37˚C. The efflux was calculated as a proportion of radioac-
tivity moved from cells to medium; non-specific efflux (i.e. the efflux to the medium without
acceptor) was subtracted.
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Confocal microscopy
For confocal microscopy studies cells were seeded in μ-slide 8-well chambers (Ibidi, USA),
grown overnight and used for further treatments. Cells were then washed with ice-cold PBS
and fixed with 4% paraformaldehyde for 15 min at room temperature. Cells were permeabi-
lised using treatment with 0.1% triton X-100 for 10 min at room temperature, washed and
blocked with 10% goat serum for 30 min. Cells were then stained with a corresponding anti-
body. Images were collected using a Nikon A1r+ confocal microscope equipped with 60x
Water Immersion objective (Nikon 60x or 40x Plan Apo VC, WI NA 1.2). Images were col-
lected with the 405, 488 and 568 lasers sequentially to minimise bleed through. Co-localisation
was quantitated using Coloc2 feature in Fiji software on at least 50 to 100 cells. The abundance
of lipid rafts was assessed using the Vybrant lipid raft labelling kit (Life Technologies) accord-
ing to manufacturer’s instructions. Briefly, cells were incubated with Alexa Fluor 488-labeled
CTB for 10 min on ice, washed, stabilized by incubation with anti-CTB antibody for 15 min at
4˚C and fixed with 4% paraformaldehyde for 15 min at room temperature. F-actin was visual-
ized with phalloidin staining according to manufacturer’s instructions (Abcam, ab176753).
Briefly, cells were fixed with formaldehyde, washed with PBS, permeabilised with 0.1% Triton
X-100 for 3–5 minutes and then washed again with PBS. Cells were incubated with phalloidin-
conjugate working solution for 20–90 minutes and washed to remove excess stain.
Inflammasome activation
Murine BMDM were seeded in 10% FBS IMDM supplemented with 10% L929 conditioned
media. The next day exosomes were added and incubated 48 h. To prime inflammasomes,
cells were incubated with LPS (100 ng/ml) for 4h. To stimulate release of Il-1β, cells were incu-
bated with Nigericin (5 μM) for 3h. Cell culture supernatants were collected to measure con-
centration of Il-1β by ELISA and abundance of p10 fragment of caspase-1 by IP. Cell lysates
were collected for estimation of procaspase-1 by Western blot.
qRT-PCR
Cells were grown in a 12 well plate and treated with exosomes for indicated periods of time.
Total RNA was extracted from these cells using TRIzol reagent from Ambion (Life Technolo-
gies, #15596018). Two μg of RNA was DNAse treated using a kit from Ambion, (#2222) from
which cDNA was made using High capacity cDNA reverse transcription kit from Applied Bio-
systems (#4368814). Primers for mouse ABCA1 and Nef were from Taqman Gene Expression
Assays (Applied Biosystems #448892). The assay was performed on a 7500 fast system from
Applied Biosystems in triplicate and the relative amount of mRNA was calculated using the
comparative Ct method with 18s rRNA as the housekeeping gene.
RNA sequencing
For RNA isolation, exosomes were prepared using PEG precipitation, resuspended in cold
PBS and centrifuged in Optima XPN-100 Ultracentrifuge (Beckman Coulter) at 100,000 x g,
4˚C for 75 min. After ultracentrifugation, pellets were resuspended in 200 μl of ice cold Exo-
some Resuspension Buffer (Total Exosome RNA & Protein Isolation Kit, Invitrogen) and
stored at -80˚C. RNA was isolated using the manufacturer’s protocol. For preparation of a
library of RNAs longer than 200 nucleotides, TruSeq Stranded mRNA kit (Illumina) was used.
Library of miRNAs was prepared using the TruSeq small RNA kit (Illumina). Both libraries
were sequenced on the Illumina NextSeq 500 machine. Single-end reads of 75 bp were
sequenced for the long RNAs and 50 bp single-end reads—for the small RNAs.
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Cdc42 activity assay
Cdc42 activity assay was done using G-LISA Cdc42 Activation assay (Cytoskeleton, Inc). This
assay detects the amount of GTP-bound (active) Cdc42. Briefly, exosomes treated RAW264.7
cells were washed with PBS and activated with bradykinin (Sigma-Aldrich) (100 ng/ml) in
serum free RPMI for 4 minutes. Cells were washed with warm serum-free RPMI, lysed and
snap frozen. Protein concentration was estimated and samples were used in G-LISA according
to manufacturer’s protocol.
ELISA for cytokines
TNFα and IL-6 in the supernatant of human monocyte derived macrophages treated with Nef
or control exosomes were measured by commercial ELISA (R&D Systems) according to man-
ufacturer’s protocol. Briefly, for cellular experiments MDM were stimulated for 24 h with
1 ng/ml LPS, supernatants were collected and used in ELISA at several dilutions. Cells were
lysed and protein concentration measured by Bradford assay (Bio-Rad). Final cytokine con-
centration was normalized to cellular protein content.
TNFα and IL-6 in murine plasma were measured by ELISA assay from Invitrogen accord-
ing to manufacturer’s instructions.
Bio-assay for cytokines
SVEC4/VCAM-1 cells were used to assess the effect of secreted cytokines on VCAM-1 expres-
sion [58]. Briefly, RAW 264.7 cells were treated with exosomes for 48h, activated with LPS
(0.1 μg/ml) for 12 h. Media was collected and spun at 100,000 x g for 70 minutes to remove
exosomes. Conditioned medium was added to SVEC4/VCAM-1 cells and incubated for 4h.
Luciferase activity was measured using Bright-Glo Luciferase Assay System (Promega).
Apoptosis and necrosis assay
The viability of RAW264.7 cells treated with exosomes was tested using a Cell Death Detection
ELISA kit (Roche). Briefly, cells were treated with exosomes for 48h, media was collected, spun
and tested for necrosis. Cells were tested for apoptosis according to kit manufacturer’s
instructions.
Lipidomics
Lipidomic analysis was performed as described previously [30]. Lipid raft fractions were com-
bined and sonicated on ice; lipids were extracted using a, single phase CHCl3:CH4OH method.
The analysis was performed by liquid chromatography electrospray ionization-tandem mass
spectrometry (LC ESI-MS/MS) using a Agilent 1200 liquid chromatography system (Agilent
Technologies) and Applied Biosystems API 4000 Q/TRAP mass spectrometer with a turbo-ion
spray source (350˚C) and Analyst 1.5 and MultiQuant data systems (AB SCIEX). Lipid con-
centrations were calculated by relating the peak area of each species to the peak area of the cor-
responding internal standard (one per group).
Animal studies
C57BL/6 mice were purchased from Jackson Laboratories and colonies were maintained at
AMREP. Mice were housed in a normal light and dark cycle and had ad libitum access to food
(normal chow) and water. C57BL/6 mice were administered either exNef (2μg, I.V.) or control
(exGFP) exosomes (2μg, I.V.), 3 times a week, for a period of 2 weeks. At the end of the experi-
ment mice were euthanized and blood was collected via cardiac puncture into EDTA tubes,
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which were immediately placed on ice. Liver and spleen were excised and peritoneal macro-
phages were collected after washing peritoneal cavity with PBS.
For flow cytometry analysis, red blood cells were lysed (BD pharm Lyse; BD Biosciences),
and white blood cells were centrifuged, washed, and resuspended in HBSS (0.1% BSA w/v, 5
mM EDTA). Cells were stained with a cocktail of antibodies against CD45-PB, Ly6-C/
G-PerCP-Cy5.5 (BD Biosciences), CD115-PE (eBioscience) and CTxB-FITC. Monocytes were
identified as CD45hiCD115hi and further subdivided into Ly6-Chi and Ly6-Clo. CTB binding
was measured as mean fluorescence intensity (MFI). Samples were run on the LSR Fortessa,
and analysed using FlowJo. Plasma total cholesterol, HDL cholesterol and triglyceride content
were measured by colorimetric assays from Wako (Japan) according to manufacturer’s
instructions.
Human studies
A cohort of subjects infected with Nef-deficient strain of HIV has been described in our previ-
ous publication [22]. Four subjects infected with WT HIV were selected from a current study.
The study details will be described elsewhere, but briefly all subjects were normolipidemic
adult males 41±8 yo, not receiving antiretroviral therapy, average CD4+ T cell count of 470
±282 cells/μl, and viral load of 8±10 x 104 copies/ml. Plasma from uninfected subjects was
obtained from healthy volunteers. Plasma samples from each group were pooled before exo-
somes were isolated as described above with following modifications: final concentration of
PEG was reduced to 5% and incubation time to 2h to avoid co-precipitation of plasma lipopro-
teins. with Isolated exosomes (final concentration 15 μg/ml of exosomal protein, unless stated
otherwise) were incubated for 48 h with murine macrophages RAW 264.7 and rafts and TRL4
were visualized and quantitated using confocal microscopy as described above.
Ethics Statement
All participants provided written informed consent and the study was approved by the Alfred
Hospital Human Research and Ethics Committee (#377/10). Plasma samples of subjects
infected with Nef-deficient HIV used in this study were from the previous studies [22, 59];
original human ethics approvals permitted for the extension of analysis of the collected sam-
ples. All participants were adults.
All animal experiments were approved by the Alfred Medical Research Education Precinct
(AMREP) animal ethics committee (#6553) and conducted in accordance with the Australian
code of practice for the care and use of animals for scientific purposes as stipulated by the
National Health and Medical Research Council of Australia. All mice were housed in a normal
light and dark cycle and had ad libitum access to food and water. Mice were randomly assigned
to treatment and end-point analysis was blinded.
Statistics
All data is shown as mean ± standard error of means (SEM) unless stated otherwise. In
box plots the horizontal line in each box indicates the median value with its height represent-
ing the 25–75th percentiles; box plot whiskers represent the extreme maximum or minimum
data points. Statistical significance of the differences was assessed in SigmaStat or GraphPad
Prism software packages by unpaired Student’s t-test or one-way ANOVA when data followed
normal distribution or Mann-Whitney U test on ranks. When comparing the effects of exo-
somes on MDM from different donors, Group analysis and two-way ANOVA were used. The
experiments were conducted in quadruplicates and repeated 2–5 times. When normalization
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of data was difficult, and the experiments were performed in multiplicates, representative
experiments out of 2–3 similar experiments are shown.
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